Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sohm Inc (SHMN)

Sohm Inc (SHMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization

CHINO HILLS, CA / ACCESS Newswire / May 2, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces...

SHMN : 0.0010 (+11.11%)
SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology

CHINO HILLS, CA / ACCESS Newswire / May 1, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies

CHINO HILLS, CA / ACCESS Newswire / April 28, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Announces Patent Allowance/Approval in South Korea

CHINO HILLS, CA / ACCESS Newswire / April 16, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE

CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announce...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations

CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce the...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology

CHINO HILLS, CA / ACCESS Newswire / March 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, has announced today Groundbreaking...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.

CHINO HILLS, CA / ACCESSWIRE / March 2, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment...

SHMN : 0.0010 (+11.11%)
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board

CHINO HILLS, CA / ACCESSWIRE / February 23, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment...

SHMN : 0.0010 (+11.11%)

Barchart Exclusives

Can Palantir Break Through Its 200-Day Moving Average on New Maven Win?
Palantir shares rallied today as the Pentagon designated Maven Smart System as a program of record. But does that warrant buying PLTR stock at roughly $160? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.